ArticleTrials2026
A multi-component family intervention to lower depression and address intimate partner violence (MILAP) among young married women in Nepal: a study protocol for a randomized controlled trial.
Article in Trials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06834867 (A Randomized Controlled Trial of a Multi-component Family Intervention to Lower Depression and Address Intimate Partner Violence), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Randomized Controlled Trial of a Multi-component Family Intervention to Lower Depression and Address Intimate Partner Violence (MILAP) Among Young Women in Nepal
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
16 authors.
Funding
Abstract
backgroundIntimate partner violence (IPV) is a well-established driver of mental health problems, often doubling the prevalence of depression. In Nepal, approximately one in four women experience IPV, with young women disproportionately affected by mental health issues. Many women in Nepal reside with their mothers-in-law (MILs), who can influence violence and restrict women's mobility, highlighting the importance of including them in interventions targeting IPV. To address this, we developed a Multi-component family Intervention to Lower depression and Address intimate Partner violence (MILAP) and will conduct a randomized controlled trial (RCT) to evaluate its effectiveness in reducing IPV and depression.
methodsThis RCT will enroll 300 family triads, each comprising a young married woman (aged 15-24), her husband, and her MIL. Blinded staff will conduct baseline assessments, after which each triad will be randomly assigned to either the MILAP or enhanced usual care (EUC). MILAP comprises nine sessions delivered by trained psychosocial counselors and focuses on strengthening the supportive relationship between MILs and daughters-in-law (DILs), providing behavioral couples therapy, and enhancing overall family dynamics. EUC includes standard care, such as individual and group counseling for IPV, enhanced with crisis counseling and referral support to ensure participant safety and access to additional resources. All participants, regardless of intervention allocation, will be assessed at baseline and at 1-, 3-, 6-, 9-, and 12-month follow-ups. These assessments will measure the following: primary outcomes (depression using Patient Health Questionnaire-9, IPV using Indian Family Violence and Control Scale); secondary outcome (post-traumatic stress disorder (PTSD) using PTSD CheckList-Civilian Version); and other outcomes. We will also conduct serial in-depth interviews to explore the mechanisms underlying MILAP's effectiveness and perform a cost-effectiveness analysis to assess its potential for scalable implementation. DISCUSSION: MILAP is a culturally adapted, family-based intervention designed to reduce IPV and depression among young Nepali women by improving communication, strengthening coping skills, and fostering supportive family relationships. This trial will assess MILAP's effectiveness, ethical rigor, cultural relevance, and scalability, with the goal of reducing IPV and improving family dynamics in low- and middle-income settings.
trial registrationThis trial is registered in ClinicalTrials.gov with the National Clinical Trial (NCT) number: NCT06834867; first registered on February 24, 2025.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.